FDA Delays Stoke Therapeutics’ Request for Epilepsy Drug Submission
Stoke Therapeutics announced that it has not reached an agreement with the Food and Drug Administration (FDA) regarding a faster filing for its drug aimed at treating severe epilepsy. In…